Centessa Pharmaceuticals plc
CNTA
$16.44
-$0.56-3.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.96% | 23.60% | 87.95% | 84.28% | -2.88% |
| Total Receivables | -6.16% | 41.77% | 15.70% | 31.76% | 65.33% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 316.07% | -47.63% | -49.12% | -51.30% | -96.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -61.01% | -38.24% | -54.37% | -52.52% | -18.44% |
| Total Current Assets | -15.51% | 22.23% | 70.24% | 70.96% | 1.45% |
|
|
|||||
| Total Current Assets | -15.51% | 22.23% | 70.24% | 70.96% | 1.45% |
| Net Property, Plant & Equipment | -8.91% | -9.39% | -9.23% | -8.82% | -8.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.54% | -8.94% | -11.08% | -7.55% | 6.71% |
| Total Assets | 23.39% | 60.84% | 60.11% | 61.57% | 1.51% |
|
|
|||||
| Total Accounts Payable | 6.99% | -31.56% | -39.54% | -31.39% | -52.01% |
| Total Accrued Expenses | 13.33% | -10.77% | 85.24% | -23.41% | -7.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.84% | 19.13% | -- | 19.71% | 20.00% |
| Total Finance Division Other Current Liabilities | -36.49% | 201.89% | -0.84% | 159.75% | 27.02% |
| Total Other Current Liabilities | -36.49% | 201.89% | -0.84% | 159.75% | 27.02% |
| Total Current Liabilities | 10.98% | -11.78% | 47.26% | -24.45% | -21.00% |
|
|
|||||
| Total Current Liabilities | 10.98% | -11.78% | 47.26% | -24.45% | -21.00% |
| Long-Term Debt | 43.20% | 42.26% | 43.91% | 2.30% | 4.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.63% | -7.19% | -6.77% | -6.40% | -6.03% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Liabilities | 31.58% | 25.30% | 41.33% | -6.27% | -3.81% |
|
|
|||||
| Common Stock & APIC | 25.74% | 39.27% | 40.33% | 41.01% | 17.53% |
| Retained Earnings | -27.60% | -28.30% | -31.31% | -22.52% | -23.23% |
| Treasury Stock & Other | -0.25% | 27.85% | 182.18% | 168.93% | 68.60% |
| Total Common Equity | 20.20% | 79.51% | 69.97% | 92.43% | 3.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.20% | 79.51% | 69.97% | 92.43% | 3.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.20% | 79.51% | 69.97% | 92.43% | 3.75% |
|
|
|||||